Stephen F Tuck

This inventor holds 19 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents, primarily in Immunomodulatory Formulations. Top assignee: Dynavax Technologies Corporation. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen F Tuck. Retrieved from https://idiyas.com/inventor/stephen-f-tuck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 36.8

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 2.7

ph-index = 13

Forward Citations = 436(Granted Patents)

Company Filing History:

19 out of 66

Dynavax Technologies Corporation

patents

Years Active: 2006-2015

Loading Chart...

Areas of Expertise:

Immunomodulatory Compounds

Biodegradable Formulations

Immune Response Modulation

Chimeric Compounds

Conjugate Molecules

Immunostimulatory Sequences

Compositions

Methods of Use

Structurally Stable

Methods of Making

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9028845 - Chimeric immunomodulatory compounds and methods of using the same-IV (2015-05-12),

2. RE45196 - Compositions comprising structurally stable conjugate molecules (2014-10-13),

3. 8669237 - Biodegradable immunomodulatory formulations and methods for use thereof (2014-03-11),

4. 8597665 - Chimeric immunomodulatory compounds and methods of using the same-IV (2013-12-03),

5. 8333980 - Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein (2012-12-18),

6. 8222398 - Chimeric immunomodulatory compounds and methods of using the same-II (2012-07-17),

7. 8124590 - Biodegradable immunomodulatory formulations and methods for use thereof (2012-02-28),

8. 8114418 - Chimeric immunomodulatory compounds and methods of using the same—IV (2012-02-14),

9. 8003115 - Chimeric immunomodulatory compounds and methods of using the same (2011-08-23),

10. 7884083 - Immunomodulatory compositions, methods of making, and methods of use thereof (2011-02-08),

11. 7785610 - Chimeric immunomodulatory compounds and methods of using the same—III (2010-08-31),

12. 7718622 - Compositions comprising structurally stable conjugate molecules (2010-05-18),

13. 7628990 - Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof (2009-12-08),

14. 7479285 - Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein (2009-01-20),

15. 7255868 - Chimeric immunomodulatory compounds and methods of using the same—I (2007-08-14),

Title: **Stephen F. Tuck: Innovator in Immunomodulatory Compounds**

Introduction

Stephen F. Tuck, based in Oakland, CA, is a prominent inventor in the field of immunology, holding a total of 19 patents. His work focuses on the development of innovative compounds that aim to enhance immunological responses.

Latest Patents

Among his recent inventions, Tuck has developed a patent titled "Chimeric immunomodulatory compounds and methods of using the same-IV." This invention provides immunomodulatory compounds and methods for adjusting the immune response in individuals. Another notable patent is for "Compositions comprising structurally stable conjugate molecules," which emphasizes the creation of stable conjugate molecules at specific temperature ranges, including structures that incorporate allergens like the Ragweed antigen Amb a 1. This work introduces methods for utilizing these compositions to modulate immune responses effectively.

Career Highlights

Stephen F. Tuck has made significant contributions to the field while working at Dynavax Technologies Corporation, a company renowned for its innovations in immunotherapy. His research and inventions demonstrate a commitment to advancing medical science and improving therapeutic interventions.

Collaborations

Throughout his career, Tuck has collaborated with esteemed colleagues such as Karen L. Fearon and Dino Dina, further enhancing the depth and breadth of his research capabilities and facilitating the development of groundbreaking medical solutions.

Conclusion

Stephen F. Tuck is an influential figure in the field of immunology, with a strong portfolio of patents that highlight his innovative spirit. His contributions continue to impact the medical field, promising advancements in the treatment and understanding of immune-related conditions through his work at Dynavax Technologies Corporation.

Profile summary based on public USPTO records.